长期不进展是对心脏再同步治疗的一种反应形式
Sander Trenson1, Peter C Kahr2, Bert Vandenberk3
1University Heart Center, University Hospital Zurich, Zurich, Switzerland; Cardiovascular Sciences, University Hospital Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University Hospital Leuven, Leuven, Belgium.
JACC. Advances
|July 27, 2025
概括
心脏再同步治疗 (CRT) 的非进展者,即没有心声学变化的患者,比进展者有更好的长期存活率. 这一缺乏特征的群体需要进一步调查,以获得最佳的心力衰竭管理.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
- 医疗器械疗法 医疗器械疗法
背景情况:
- 心脏再同步治疗 (CRT) 改善了心力衰竭患者的选择结果.
- 一小部分患者被称为"非进展者",在CRT后没有表现出心声学变化.
- 了解非进展性结果对于完善CRT患者选择和管理至关重要.
研究的目的:
- 调查心力衰竭患者的长期预后,这些患者在CRT后被确定为"非进展者".
- 将非进步者的结果与CRT后的其他响应类别进行比较.
主要方法:
- 对391名接受CRT植入的患者进行了回顾性队列分析.
- 根据心声回应分类的患者:超级响应者 (>15%的LVEF增加),响应者 (>5%的LVEF增加),非进展者 (±5%的LVEF变化) 和进展者 (<-5%的LVEF减少).
- 主要组合结局:全因死亡,心室辅助装置植入或心脏移植,使用考克斯回归和卡普兰-梅尔曲线进行分析.
主要成果:
- 34%的患者 (134/391) 被归类为非进展者.
- 与非进展者相比,进展者的复合终点风险明显更高 (调整后HR为2.26).
- 超级响应者和响应者表现得明显好于非进展者.
结论:
- 非进步者在CRT接受者中代表着一个重要的,研究不足的群体.
- 非进步者的长期存活率明显好于进步者或负面反应者.
- 需要进一步的研究,以充分描述非进步者队列及其特定的管理需求.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
01:29Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
33
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
33
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
01:30Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
01:30Cardiac Action Potential
2.6K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
2.6K